Cargando…

3D Bioprinting for Next-Generation Personalized Medicine

In the past decade, immense progress has been made in advancing personalized medicine to effectively address patient-specific disease complexities in order to develop individualized treatment strategies. In particular, the emergence of 3D bioprinting for in vitro models of tissue and organ engineeri...

Descripción completa

Detalles Bibliográficos
Autores principales: Lam, Ethan Hau Yin, Yu, Fengqing, Zhu, Sabrina, Wang, Zongjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094501/
https://www.ncbi.nlm.nih.gov/pubmed/37047328
http://dx.doi.org/10.3390/ijms24076357
_version_ 1785023857123393536
author Lam, Ethan Hau Yin
Yu, Fengqing
Zhu, Sabrina
Wang, Zongjie
author_facet Lam, Ethan Hau Yin
Yu, Fengqing
Zhu, Sabrina
Wang, Zongjie
author_sort Lam, Ethan Hau Yin
collection PubMed
description In the past decade, immense progress has been made in advancing personalized medicine to effectively address patient-specific disease complexities in order to develop individualized treatment strategies. In particular, the emergence of 3D bioprinting for in vitro models of tissue and organ engineering presents novel opportunities to improve personalized medicine. However, the existing bioprinted constructs are not yet able to fulfill the ultimate goal: an anatomically realistic organ with mature biological functions. Current bioprinting approaches have technical challenges in terms of precise cell deposition, effective differentiation, proper vascularization, and innervation. This review introduces the principles and realizations of bioprinting with a strong focus on the predominant techniques, including extrusion printing and digital light processing (DLP). We further discussed the applications of bioprinted constructs, including the engraftment of stem cells as personalized implants for regenerative medicine and in vitro high-throughput drug development models for drug discovery. While no one-size-fits-all approach to bioprinting has emerged, the rapid progress and promising results of preliminary studies have demonstrated that bioprinting could serve as an empowering technology to resolve critical challenges in personalized medicine.
format Online
Article
Text
id pubmed-10094501
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100945012023-04-13 3D Bioprinting for Next-Generation Personalized Medicine Lam, Ethan Hau Yin Yu, Fengqing Zhu, Sabrina Wang, Zongjie Int J Mol Sci Review In the past decade, immense progress has been made in advancing personalized medicine to effectively address patient-specific disease complexities in order to develop individualized treatment strategies. In particular, the emergence of 3D bioprinting for in vitro models of tissue and organ engineering presents novel opportunities to improve personalized medicine. However, the existing bioprinted constructs are not yet able to fulfill the ultimate goal: an anatomically realistic organ with mature biological functions. Current bioprinting approaches have technical challenges in terms of precise cell deposition, effective differentiation, proper vascularization, and innervation. This review introduces the principles and realizations of bioprinting with a strong focus on the predominant techniques, including extrusion printing and digital light processing (DLP). We further discussed the applications of bioprinted constructs, including the engraftment of stem cells as personalized implants for regenerative medicine and in vitro high-throughput drug development models for drug discovery. While no one-size-fits-all approach to bioprinting has emerged, the rapid progress and promising results of preliminary studies have demonstrated that bioprinting could serve as an empowering technology to resolve critical challenges in personalized medicine. MDPI 2023-03-28 /pmc/articles/PMC10094501/ /pubmed/37047328 http://dx.doi.org/10.3390/ijms24076357 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Lam, Ethan Hau Yin
Yu, Fengqing
Zhu, Sabrina
Wang, Zongjie
3D Bioprinting for Next-Generation Personalized Medicine
title 3D Bioprinting for Next-Generation Personalized Medicine
title_full 3D Bioprinting for Next-Generation Personalized Medicine
title_fullStr 3D Bioprinting for Next-Generation Personalized Medicine
title_full_unstemmed 3D Bioprinting for Next-Generation Personalized Medicine
title_short 3D Bioprinting for Next-Generation Personalized Medicine
title_sort 3d bioprinting for next-generation personalized medicine
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094501/
https://www.ncbi.nlm.nih.gov/pubmed/37047328
http://dx.doi.org/10.3390/ijms24076357
work_keys_str_mv AT lamethanhauyin 3dbioprintingfornextgenerationpersonalizedmedicine
AT yufengqing 3dbioprintingfornextgenerationpersonalizedmedicine
AT zhusabrina 3dbioprintingfornextgenerationpersonalizedmedicine
AT wangzongjie 3dbioprintingfornextgenerationpersonalizedmedicine